| Product Code: ETC9519595 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname pneumococcal vaccine import market saw significant growth in 2024, with key exporting countries such as Brazil, India, USA, Netherlands, and France dominating the market. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), increased from high to very high in 2024, indicating a more consolidated market. The impressive Compound Annual Growth Rate (CAGR) of 10.35% from 2020 to 2024, along with a remarkable growth rate of 111.98% in 2023-24, highlights the strong demand for pneumococcal vaccines in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Pneumococcal Vaccine Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Suriname Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Suriname Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Suriname Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Suriname Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Suriname Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Suriname Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and programs to promote vaccination in Suriname |
4.2.2 Growing awareness among the population about the importance of pneumococcal vaccination |
4.2.3 Rise in healthcare expenditure and infrastructure development in Suriname |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities and vaccination services in remote areas of Suriname |
4.3.2 High cost of pneumococcal vaccines and related healthcare services in the country |
5 Suriname Pneumococcal Vaccine Market Trends |
6 Suriname Pneumococcal Vaccine Market, By Types |
6.1 Suriname Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Suriname Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Suriname Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Suriname Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Suriname Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Suriname Pneumococcal Vaccine Market Export to Major Countries |
7.2 Suriname Pneumococcal Vaccine Market Imports from Major Countries |
8 Suriname Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Percentage increase in the number of individuals vaccinated against pneumococcal disease |
8.2 Improvement in vaccination coverage rates among high-risk populations |
8.3 Reduction in the incidence of pneumococcal-related illnesses and hospitalizations |
9 Suriname Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Suriname Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Suriname Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Suriname Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Suriname Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Suriname Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Suriname Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Suriname Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |